A research team at Yangzhou University’s Institute of Translational Medicine introduces a LepR-targeted nitric oxide nanopump (CB-LepR) that chemically excites BNN6 using endogenous H₂O₂ to achieve sustained in situ NO release within senescent LepR⁺ cells. This approach scavenges excess H₂O₂, reactivates glycolysis signaling, and restores HSC niches, vascular and neural support, effectively reversing age-induced bone marrow collapse in murine models.
Key points
- CB-LepR nanopump co-encapsulates CPPO and BNN6 in a DSPE-PEG-MAL/soybean oil matrix functionalized with a LepR antibody for targeted delivery.
- Elevated H₂O₂ in aged bone marrow initiates peroxyoxalate chemiexcitation to produce ¹,²-dioxetanedione, directly exciting BNN6 and triggering sustained intracellular NO release.
- Targeted NO release in LepR⁺ cells reactivates glycolysis, reduces senescence markers, and restores hematopoietic, vascular, lymphatic, and neural support in aged murine bone marrow.
Why it matters: This targeted nanodelivery system offers a paradigm-shifting strategy to restore aging bone marrow function and combat age-related hematopoietic decline.
Q&A
- What are LepR⁺ cells?
- How does the peroxyoxalate-based chemiexcitation mechanism work?
- Why target H₂O₂ in aged bone marrow?
- How does nitric oxide restore glycolysis in senescent cells?